Tudor Investment Corporation »

Ambrx Biopharma shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $154k 11k 14.24

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Pioneer Natural Resources Co - US Equity (PXD)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Meta Platforms Inc - US Equity (META)
Spdr S&P 500 Etf Trust - US ETP Exchange-Traded Fund (SPY)
Utilities Select Sector Spdr Fund - US ETP ETF Option Put Option (XLU)
Humana Inc - US Equity (HUM)
Nvidia Corp - US Equity (NVDA)
Apple Inc - US Equity (AAPL)
Eli Lilly & Co - US Equity Option Call Option (LLY)
Unitedhealth Group Inc - US Equity (UNH)
Advanced Micro Devices Inc - US Equity (AMD)
Micron Technology Inc - US Equity (MU)
Nike Inc - US Class B Equity (NKE)

View all positions for Tudor Investment Corporation

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma